Lyra Therapeutics (LYRA) Institutional Ownership $0.21 +0.01 (+4.10%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$0.21 +0.00 (+0.15%) As of 02/21/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Lyra Therapeutics (NASDAQ:LYRA)CurrentInstitutional OwnershipPercentage95.62%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$3.11MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$6.09M Get LYRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Lyra Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LYRA Institutional Buying and Selling by Quarter Lyra Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Two Sigma Investments LP209,997$43K0.0%-25.7%0.321% 2/17/2025 Two Sigma Advisers LP385,500$80K0.0%-16.3%0.589% 2/17/2025 BNP Paribas Financial Markets244,920$51K0.0%N/A0.374% 2/14/2025 Samsara BioCapital LLC1,965,689$406K0.1%-29.3%3.003% 2/14/2025 Northern Trust Corp286,310$59K0.0%+56.2%0.437% 2/13/2025 ADAR1 Capital Management LLC533,200$110K0.0%N/A0.815% 2/12/2025 Geode Capital Management LLC885,966$183K0.0%+15.3%1.353% 2/12/2025 JPMorgan Chase & Co.156,442$32K0.0%+161.8%0.239% 11/15/2024 State Street Corp488,720$126K0.0%+88.1%0.747% 8/6/2024 Acadian Asset Management LLC985,631$271K0.0%N/A1.617% Get the Latest News and Ratings for LYRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lyra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/12/2024 Rosalind Advisors Inc.1,034,773$286K0.2%-9.6%1.697% 5/17/2024 Ikarian Capital LLC1,056,829$6.57M0.7%-15.7%1.733% 5/10/2024 Vanguard Group Inc.1,481,481$9.22M0.0%+38.3%2.430% 4/25/2024 Rosalind Advisors Inc.1,144,524$7.12M6.7%-39.4%1.916% 2/15/2024 Parkman Healthcare Partners LLC754,885$3.96M0.6%+20.8%1.436% 2/14/2024 Vestal Point Capital LP3,000,000$15.72M1.7%N/A5.708% 2/13/2024 Armistice Capital LLC1,088,000$5.70M0.1%-29.8%2.070% 2/7/2024 Jump Financial LLC16,737$88K0.0%N/A0.032% 1/25/2024 Heritage Wealth Management Inc. Texas10,000$52K0.0%N/A0.019% 12/6/2023 Citigroup Inc.67,677$265K0.0%N/A0.129% 11/15/2023 Armistice Capital LLC1,550,000$6.06M0.1%-61.4%2.949% 11/14/2023 Prescott Group Capital Management L.L.C.30,000$117K0.0%N/A0.057% 10/24/2023 Bank of New York Mellon Corp18,621$73K0.0%N/A0.038% 8/24/2023 Perceptive Advisors LLC12,757,562$52.43M1.5%+39.5%25.747% 8/14/2023 Samsara BioCapital LLC2,780,261$11.43M2.0%+56.4%8.733% 8/14/2023 Pura Vida Investments LLC1,413,242$5.72M0.8%-29.2%4.439% 8/10/2023 Letko Brosseau & Associates Inc.31,900$131K0.0%N/A0.100% 2/15/2023 Nantahala Capital Management LLC2,220,830$6.97M0.5%-1.1%6.977% 2/14/2023 Pura Vida Investments LLC2,157,298$6.77M0.3%-14.1%6.778% 11/15/2022 Pura Vida Investments LLC2,510,302$12.58M0.7%-2.6%7.888% 11/14/2022 Boothbay Fund Management LLC34,721$174K0.0%-9.5%0.109% 11/10/2022 Nantahala Capital Management LLC2,245,830$11.25M0.7%-5.2%17.262% 8/16/2022 Pura Vida Investments LLC2,576,196$14.56M0.8%+394.9%19.802% 8/16/2022CVI Holdings LLC60,822$344K0.0%N/A0.468% 8/15/2022 Nantahala Capital Management LLC2,369,668$13.39M0.7%N/A18.214% 8/12/2022 Ensign Peak Advisors Inc56,229$318K0.0%+43.6%0.432% 8/12/2022 Ikarian Capital LLC347,338$1.96M0.4%-17.8%2.670% 5/16/2022 Clearline Capital LP119,924$482K0.1%+84.9%0.922% 2/14/2022 Clearline Capital LP64,862$283K0.0%N/A0.499% 2/14/2022 Soleus Capital Management L.P.10,000$44K0.0%-95.4%0.077% Collect $7k per month from Tesla’s SECRET dividend (Ad)There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?Click here to uncover Tesla's hidden income secret.2/11/2022 Pentwater Capital Management LP71,313$311K0.0%+122.8%0.548% 11/16/2021 Two Sigma Advisers LP58,000$529K0.0%+31.8%0.446% 11/15/2021 Pura Vida Investments LLC533,417$4.87M0.1%-1.7%4.103% 11/15/2021 Marshall Wace LLP12,457$114K0.0%-35.5%0.096% 11/9/2021BlackRock Inc.17,818$163K0.0%-11.4%0.137% 11/4/2021 Close Asset Management Ltd7,000$64K0.0%N/A0.054% 8/25/2021 Marshall Wace LLP19,321$155K0.0%-58.8%0.149% 8/18/2021 Ikarian Capital LLC624,684$5.02M0.4%-20.0%4.805% 8/17/2021 Walleye Capital LLC19,093$153K0.0%N/A0.147% 8/17/2021 Millennium Management LLC155,135$1.25M0.0%N/A1.193% 8/17/2021 Bridgeway Capital Management LLC41,900$336K0.0%-14.5%0.322% 8/16/2021Tibra Equities Europe Ltd40,000$321K0.1%N/A0.308% 8/16/2021 Marshall Wace LLP19,321$155K0.0%-58.8%0.149% 8/13/2021 Geode Capital Management LLC36,102$289K0.0%-60.0%0.278% 8/13/2021 Vanguard Group Inc.220,029$1.77M0.0%+3.8%1.692% 8/12/2021 Trexquant Investment LP11,610$93K0.0%N/A0.089% 8/12/2021Ergoteles LLC31,000$249K0.0%N/A0.238% 8/11/2021 Deutsche Bank AG76,441$614K0.0%-5.4%0.588% 8/11/2021 Susquehanna International Group LLP21,529$173K0.0%N/A0.166% 8/2/2021 Advisor Group Holdings Inc.4,434$36K0.0%-89.6%0.034% 5/18/2021 Morgan Stanley107,217$1.24M0.0%+655.0%0.825% 5/17/2021 Nuveen Asset Management LLC17,913$208K0.0%N/A0.138% 5/17/2021 Ikarian Capital LLC780,728$9.05M0.3%-4.2%6.005% 5/13/2021 Bank of New York Mellon Corp15,036$174K0.0%-22.7%0.116% 5/13/2021 Blair William & Co. IL55,000$637K0.0%N/A0.424% 5/12/2021 Northern Trust Corp64,451$746K0.0%-5.2%0.497% 5/12/2021 Geode Capital Management LLC90,281$1.05M0.0%+31.8%0.696% 5/12/2021 JPMorgan Chase & Co.147,400$1.71M0.0%-22.8%1.137% 5/7/2021BlackRock Inc.348,394$4.04M0.0%+31.9%2.688% 5/4/2021 Envestnet Asset Management Inc.36,792$426K0.0%N/A0.284% 2/19/2021 JPMorgan Chase & Co.191,000$2.18M0.0%+9,858.3%1.478% 2/16/2021 Charles Schwab Investment Management Inc.14,177$162K0.0%N/A0.110% 2/13/2021 American International Group Inc.3,954$45K0.0%+60.9%0.031% 2/12/2021 Ikarian Capital LLC815,364$9.30M0.4%+110.2%6.307% 2/11/2021 Northern Trust Corp67,995$775K0.0%+39.1%0.526% 2/9/2021 Wells Fargo & Company MN3,521$40K0.0%+225.1%0.027% 2/9/2021 Bank of New York Mellon Corp19,450$222K0.0%+24.3%0.150% 2/5/2021BlackRock Inc.264,165$3.01M0.0%+27.4%2.044% (Data available from 1/1/2016 forward) LYRA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LYRA shares? During the previous two years, 24 institutional investors and hedge funds held shares of Lyra Therapeutics. The most heavily invested institutionals were Perceptive Advisors LLC ($52.43M), Vestal Point Capital LP ($15.72M), Vanguard Group Inc. ($9.22M), Ikarian Capital LLC ($6.57M), Pura Vida Investments LLC ($5.72M), Armistice Capital LLC ($5.70M), and Parkman Healthcare Partners LLC ($3.96M).Learn more on LYRA's institutional investors. What percentage of Lyra Therapeutics stock is owned by institutional investors? 95.62% of Lyra Therapeutics stock is owned by institutional investors. Learn more on LYRA's institutional investor holdings. Which institutional investors have been buying Lyra Therapeutics stock? Of the 18 institutional investors that purchased Lyra Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Perceptive Advisors LLC ($3.61M), Vestal Point Capital LP ($3M), Samsara BioCapital LLC ($1.00M), Acadian Asset Management LLC ($985.63K), ADAR1 Capital Management LLC ($533.20K), Vanguard Group Inc. ($410.02K), and BNP Paribas Financial Markets ($244.92K). How much institutional buying is happening at Lyra Therapeutics? Institutional investors have bought a total of 10,638,563 shares in the last 24 months. This purchase volume represents approximately $39.20M in transactions. Which Lyra Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Lyra Therapeutics stock in the last 24 months: Armistice Capital LLC ($2.92M), Rosalind Advisors Inc. ($853.95K), Samsara BioCapital LLC ($814.57K), Pura Vida Investments LLC ($583.73K), Ikarian Capital LLC ($197.56K), Two Sigma Advisers LP ($74.80K), and Two Sigma Investments LP ($72.55K). How much institutional selling is happening at Lyra Therapeutics? Institutional investors have sold a total of 5,521,190 shares in the last 24 months. This volume of shares sold represents approximately $20.53M in transactions. Related Companies OM Institutional Ownership MODD Institutional Ownership NXL Institutional Ownership BDMD Institutional Ownership CLGN Institutional Ownership MBOT Institutional Ownership MDAI Institutional Ownership NMTC Institutional Ownership FEMY Institutional Ownership DXR Institutional Ownership This page (NASDAQ:LYRA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lyra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LYRA Stock Alerts